microRNA in Patients with Hepatitis B and Hepatitis C Virus Associated Hepatocellular Carcinoma and Cirrhosis
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 3
Abstract
Objectives: The aim of this study was to determine the potentials of hsa-microRNAs (miRNA)-21-3p, hsa-miRNA-29a-3p, hsa-miRNA-122-3p, hsa-miRNA-192-5p in Hepatitis B (HBV) and HCV related hepatocellular carcinoma (HCC) and liver cirrhosis (LC) cases, being biomarkers by examining their levels. Materials and Methods: Sixty patients and 26 healthy volunteers were included in the study. Total RNA isolation in the serum samples was performed with the Direct-zolTM RNA MiniPrep (Zymo Research Corp., USA) commercial kit followed by cDNA synthesis and real-time polymerase chain reaction amplification with EPIK miRNA Select Hi/Lo-ROX (Bioline Reagents Ltd., USA). For amplification and analysis, Rotor-Gene Q (QIAGEN, Germany) instrument was used and statistical analyzes were performed with SPSS 21 (IBM, USA) program. Results: Hsa-miRNA-21-3p and hsa-miRNA-122-3p levels increased 3-4 fold in patients without HCV related LC (HCV-LC) and hsa-miRNA- 29a-3p expression in HCV infected patients has significantly decreased (p<0.05). hsa-miRNA-192-5p showed a 3-fold increase in HBV related LC (HBV-LC) group (p<0.05) but not in other groups. The hsa-miRNA-122-3p value is increased in HCV-LC patients. Conclusion: In our study, miRNA-21-3p and hsa-miRNA-122 for HBV-HCC and HCV-HCC diseases; hsa-miRNA-21-3p, hsa-miRNA- 122 and hsa-miRNA-192-5p for HBV-LC; miRNA-29a-3p test for HCV-LC could be used as diagnostic markers.
Authors and Affiliations
Gökhan Küçükkara, Ferhat Gürkan Aslan, Bilal Toka, Mehmet Köroğlu, Mustafa Altındiş
Keywords
Related Articles
- EP ID EP676550
- DOI 10.4274/vhd.galenos.2019.2019.0027
- Views 134
- Downloads 0
Prevalence of Hepatitis B and C Infection in Patients with Rheumatoid Arthritis in Marrakesh
Objectives: Although there is no difference in frequency of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with rheumatoid arthritis (RA) in general population, multicenter studies are needed a...
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C have been revolutionised. In the meantime, hepatitis C patients with sustained virologic response (SVR) achieved with previous treatments hav...
Relationship between Viral Load and Hepatic Histopathology in Patients with Chronic Hepatitis B
Objectives: It is not always possible to determine a clear relationship between the DNA level of hepatitis B virus (HBV) and histology. In this study, we aimed to determine the relationship between HBV-DNA level and live...
The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Material...
The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy
Objectives: Immunosuppressive (IS) therapies present a risk of reactivation in patients with previous or known hepatitis B virus (HBV) infection and may cause mortality and morbidity. Before starting these therapies, pat...